Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Shoichiro Irimajiri"'
Autor:
Shinichi Yoshino, Nobuo Matsui, Tohru Abe, Masako Hara, Masashi Nobunaga, Keiko Hoshi, Yutaka Mizushima, Hiroshi Hashimoto, Shigeyuki Nakano, Shoichiro Irimajiri, Sachiko Sugawara
Publikováno v:
Modern Rheumatology. 17:1-9
We conducted a 28-week, randomized, double-blind, parallel-group study of iguratimod in 376 Japanese patients with active rheumatoid arthritis to compare the efficacy and safety of the drug with those of placebo and salazosulfapyridine. In the Americ
Autor:
Masako Hara, Yutaka Mizushima, Shoichiro Irimajiri, Sachiko Sugawara, Shinichi Yoshino, Tohru Abe, Nobuo Matsui, Masashi Nobunaga, Keiko Hoshi, Hiroshi Hashimoto
Publikováno v:
Modern Rheumatology. 17:10-16
We conducted a 52-week clinical study of iguratimod in 394 Japanese patients with rheumatoid arthritis to evaluate the long-term safety of the drug. Iguratimod was administered orally at a daily dose of 25 mg for the first 4 weeks and 50 mg for the s
Autor:
Shoji Uchida, Masako Hara, Shoichiro Irimajiri, Sachiko Sugawara, Shunichi Hirose, Hirobumi Kondo, Sadao Kashiwazaki
Publikováno v:
Ensho Saisei. 22:213-226
We conducted a preliminary study to evaluate the efficacy and safety of FK 506 for rheumatoid arthritis (RA) patients. Subjects were 29 RA patients in an active state. The trial was of an open, uncontrolled design, with a comparison of 2 treatment sc
Autor:
Ryuki Kim, Yoshihiko Takizawa, Shoichiro Irimajiri, Tomonobu Aoki, Mitsuo Obana, Tsunoda T, Hiroko Sagara, Kazuyo Yamashita
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 76:355-368
The patients or carriers with infectious enteritis admitted to the Hospitals for infectious diseases in the last 5 years (1996-2000) were studied. The total number of cases admitted in each year were 969, 1,113, 981, 637 and 573 respectively. A total
Autor:
Shoichiro Irimajiri
Publikováno v:
Nihon Naika Gakkai Zasshi. 87:2383-2389
膠原病とは多臓器症状を示す全身性系統的疾患群を指す.そして同じ膠原病の範疇に入る疾患群でもそれぞれ異なった臨床症状と免疫学的異常という背景を有している.本稿では膠原病の
Publikováno v:
Clinical Endocrinology. 47:619-622
We describe a case of well-differentiated Sertoli-Leydig cell tumour (SLCT) of the ovary. A 48-year-old Japanese woman had had symptoms of virilization, i.e. alopecia and facial hair, for 8 years. Although the patient had given birth to three normal
Autor:
Reiji Kasukawa, Takeshi Azuma, Hiroshi Hashimoto, Shinichi Yoshino, Terunobu Saito, Akira Murasawa, Shogo Kano, Sadao Kashiwazaki, Yutaka Mizushima, Hirobumi Kondo, Shoichiro Irimajiri, Tomihisa Koshino, Ikuo Nagaya, Yoshifuji Matsumoto, Shigeaki Imura, Hidemitsu Ezawa
Publikováno v:
Ensho. 17:57-80
The clinical efficacy of an extracorporeal granulocyte removal column (G-1) was investigated in two groups of patients with rheumatoid arthritis (RA) . Group I (n=85) received a total of 4 apheresis, one apheresis per week ; Group II (n=79) received
Autor:
Atsushi Suzuki, Yasuo Matsuoka, Shoichiro Irimajiri, Junya Fukuda, Kana Harada, Takahiro Suzuki, Mitsuo Obana
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 71:1066-1070
A 80-year-olkd male was admitted to our hospital because of severe pain and swelling on his left lower leg on January 23, 1996. He had received an acupuncture to both legs because of intermittent claudication once a week from July, 1995 to January 18
Autor:
Teruhiko Suzuki, Masako Hara, Mitsuyoshi Nakashima, Shoichiro Irimajiri, Miyako Ishigami, Takeshi Tojo, Toru Hayashi, Atsushi Suzuki, Fumihiko Imai, Wataru Hirose, Sadao Kashiwazaki, Haruaki Warabi, Yasuo Matsuoka, Yoshinari Takasaki, Mitsuhiro Kawagoe, Ayako Nakajima, Sachiko Sugawara
Publikováno v:
Ensho. 17:173-193
A double-blind comparative study among 9 medical centers was conducted in order to investigate the optimal daily administration schedule of UHAC62 (Generic name: Meloxicam), a kind of non-steroidal anti-inflammatory oxycam agent. The daily 10 mg of U
Autor:
Masashi Akizuki, Mikio Shimizu, Yasuo Ohosone, Tsuneyo Mimori, Shoichiro Irimajiri, Kiyomitsu Miyachi, Yasuo Matsuoka, Mami Matsumura
Publikováno v:
Arthritis & Rheumatism. 39:1308-1312
Objective. To identify and characterize a novel autoantibody, anti-WS, that binds total transfer RNA (tRNA). Methods. Serum from patient WS, who had polyarthritis, Sjogren's syndrome, Raynaud's phenomenon, and interstitial pulmonary fibrosis, was use